HALO
Halozyme Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD69.82
+3.54 (+5.34%)
Rating:B+
Company Profile
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$66.00
Prev. Close
$66.28
Day Low
$66.00
Day High
$70.13
52W Low
$51.06
52W High
$82.22
Market Cap
$8.28B
Volume
2.14M